Table 2.
Human Immunodeficiency Virus (HIV) Care Indicators Among Persons With Newly Diagnosed HIV or AIDS by Year, 2009–2014, San Francisco
| Indicator | Persons With Newly Diagnosed HIV or AIDS by Year of Diagnosis, % | P Value for Trend Testa | |||||
|---|---|---|---|---|---|---|---|
| 2009 (n = 473) | 2010 (n = 451) |
2011 (n = 422) |
2012 (n = 456) | 2013 (n = 399) | 2014 (n = 329) |
||
| Linked to care ≤3 mo after diagnosis | 85.8 | 84.3 | 85.8 | 87.7 | 83.5 | 91.8 | .04b |
| Retained in care 6–12 mo after linkage | 70.2 | 65.9 | 71.1 | 69.8 | 67.2 | 72.6 | .26 |
| Starting ART ≤12 mo after diagnosis | 63.2 | 72.9 | 78.6 | 85.6 | 84.6 | 90.7 | <.001b |
| Virally suppressed ≤12 mo after diagnosisc | 49.2 | 59.5 | 63.2 | 72.6 | 73.2 | 82.3 | <.001b |
| Development of AIDS ≤3 mo after diagnosis | 26.9 | 26.6 | 23.9 | 21.1 | 18.3 | 16.4 | <.001b |
| Death ≤12 mo after diagnosis | 3.0 | 2.9 | 2.6 | 0.9 | 3.8 | 1.2 | .12 |
Abbreviations: ART, antiretroviral therapy; HIV, human immunodeficiency virus.
a P values based on 1-sided Cochran-Armitage trend test.
bSignificant at P < .05.
cViral suppression is defined as a viral load <200/copies/mL.